HORIZON-PFT: Pivotal Fracture Trial.
Phase of Trial: Phase III
Latest Information Update: 11 Sep 2017
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Fracture; Postmenopausal osteoporosis; Vertebral fracture
- Focus Registrational; Therapeutic Use
- Acronyms HORIZON-PFT
- Sponsors Novartis Pharmaceuticals
- 16 Oct 2012 Extension study results presented at the 34th Annual Meeting of the American Society for Bone and Mineral Research.
- 01 Aug 2012 Results published in the Journal of Bone and Mineral Research.
- 24 Mar 2012 Results assessing renal function presented at the 2012 IOF World Congress on Osteoporosis and 11th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History